Skip to main content
SpringerPlus
Fig. 3 | SpringerPlus

Fig. 3

From: Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the disease

Fig. 3

Serial monitoring of circulating DNA in the plasma during the treatment process. a Patient group that did not harbor T790M at baseline. 7 samples indicated the presence of T790M with ctDNA analysis at the end of 6 months. b Patient group that harbored T790M at baseline. Patients 29 and 32 died before the end of the study and specific data points cannot be obtained. 2 samples indicated the absence of T790M mutations in ctDNA. c cfDNA serial measurements for the 2 groups of patients for disease monitoring

Back to article page